Antibody Drug Conjugates (ADC) Market by Global Demand, Supply and Research Synopsis

1
Antibody Drug Conjugates (ADC) Market by Global
Demand, Supply and Research Synopsis
Antibody Drug Conjugates (ADC) Market, By Target
(Antibody-Protein Toxin Conjugates,
Antibody-Chelated Radionuclide Conjugates,
Antibody-Small-Molecule Drug Conjugates,
Antibody-Enzyme Conjugates), Product (Adcertis,
Kadcyla, Others), Mechanism of Action (CD30
Antibodies, HER2 Antibodies), Technology
(Immunogen Technology, Seattle Genetics
Technology, Immunomedics Technology, Others),
Indication (Lymphoma, Breast Cancer, Brain Tumor,
Lung Cancer, Ovarian Cancer, Others), End-Users
(Hospitals, Specialty Clinics, Others),
Distribution Channel (Hospital Pharmacy, Retail
Pharmacy, Others), Industry Trends and Forecast
to 2029.
Browse Full Report https//www.databridgemarke
tresearch.com/reports/global-antibody-drug-conjuga
tes-market
2
Market Analysis and Insights
Antibody drug conjugates (ADC) market size is
projected to grow at a compound annual growth
rate of 23.7 over the forecast period of 2022 to
2029. Data Bridge Market Research report on
antibody drug conjugates (ADC) market provides
analysis and insights regarding the various
factors expected to be prevalent throughout the
forecasted period while providing their impacts
on the markets growth. Antibody drug conjugates
are basically the biopharmaceuticals agents that
are manufactured for targeted therapy of cancer
treatment. They are covalently linked to the
antibody or antibody fragment that directed
towards the specific cell surface target
expressed on the tumor cells. They are combined
with monoclonal antibodies to target the cancer
cells and act by specifically targeting to the
tumor antigen surface, the complex internalized
into the cells.
Get Exclusive Sample Report https//www.databri
dgemarketresearch.com/request-a-sample/?dbmrgloba
l-antibody-drug-conjugates-market
3
Image
4
Major Key Players

• Some of the major players operating in this
  market are
• Seagen Inc.
• Genentech Inc.
• Pfizer Inc.
• Novartis AG
• F. Hoffmann-LA Roche Ltd.
• Bristol -Myers Squibb
• Merck Co., Inc
• Immunomedics Inc.,
• Takeda Pharmaceutical Company Limited
• Onconova Therapeutics

Inquire Before Buying https//www.databridgemark
etresearch.com/inquire-before-buying/?dbmrglobal-
antibody-drug-conjugates-market
5
Market Segmentation

• By Target (Antibody-Protein Toxin Conjugates,
  Antibody-Chelated Radionuclide Conjugates,
  Antibody-Small-Molecule Drug Conjugates,
  Antibody-Enzyme Conjugates)
• By Product (Adcertis, Kadcyla, Others)
• By Technology (Immunogen Technology, Seattle
  Genetics Technology, Immunomedics Technology,
  Others)

Browse Full TOC _at_ https//www.databridgemarketre
search.com/toc/?dbmrglobal-antibody-drug-conjugat
es-market
6
Regional Analysis

• Based on geography, the market is segmented into
  five geographical regions
• North America
• Europe
• Asia-Pacific
• South America
• Middle East
• Africa

7
About Data Bridge Market Research
An absolute way to forecast what future holds is
to comprehend the trend today! Data Bridge Market
Research set forth itself as an unconventional
and neoteric Market research and consulting firm
with unparalleled level of resilience and
integrated approaches. We are determined to
unearth  the best market opportunities and foster
efficient information for your business to thrive
in the market. Data Bridge endeavors to provide
appropriate solutions to the complex business
challenges and initiates an effortless
decision-making process. Read Continue
http//databridgemarketresearch.com/about-us/
Contact Us Sopan Gedam Sopan.gedam_at_databridge
marketresearch.com